Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2005
09/28/2005EP1579872A1 Body weight gain inhibitor
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1579868A2 Use of IL-11 for treating various diseases
09/28/2005EP1579855A1 Novel dry powder inhalation system for transpulmonary administration
09/28/2005EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
09/28/2005EP1578926A2 Novel prostate tumor-specific promoter
09/28/2005EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578722A2 Kinase inhibitor scaffolds and methods for their preparation
09/28/2005EP1578721A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
09/28/2005EP1578345A2 Peptides and antibodies to muc 1 proteins
09/28/2005EP1463731B1 Dibenzodiazepine derivates, their preparation and use
09/28/2005EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
09/28/2005EP1401438B1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
09/28/2005EP1397348B1 Factor xa inhibitor
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1356277A4 Method for altering cell fate
09/28/2005EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/28/2005EP1318815B1 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
09/28/2005EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1267905B1 Composition for the treatment of heart failure
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1255546B9 Method for improving bone modeling and chondrocyte functioning in growing canines
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1225173B1 Naphthyridine derivatives
09/28/2005EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1141006B1 Topoisomerase ii inhibitor
09/28/2005EP1104294B1 Compositions and methods of treating abnormal cell proliferation
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005EP0944639A4 Synthetic glycoamines, methods for their use that affect cell
09/28/2005EP0767835B1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
09/28/2005EP0646022B1 Prosthetic devices having enhanced osteogenic properties
09/28/2005CN1675363A T-cell epitopes in staphylococcal enterotoxin B
09/28/2005CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof
09/28/2005CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
09/28/2005CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
09/28/2005CN1675233A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
09/28/2005CN1675232A Derivatives of monosaccharides for drug discovery
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675222A C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675215A Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
09/28/2005CN1675214A Pyrimido compounds having antiproliferative activity
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675195A Inhibitors of tyrosine kinases
09/28/2005CN1675194A Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
09/28/2005CN1675193A Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide
09/28/2005CN1675192A Novel compunds, pharmaceutical compositions containing same, and methods of use for same
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1675180A Indole, indazole, and benzazole derivative
09/28/2005CN1675173A Muscarinic agonists
09/28/2005CN1675169A Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674959A Use of a PPAR-alpha agonist to treat weight gain associated with a PPAR-gamma agonist treatment
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674939A Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD
09/28/2005CN1674937A Remedy or preventive for kidney disease and method of diagnosing kidney disease
09/28/2005CN1674927A Growth hormone releasing peptides
09/28/2005CN1674926A Remedy
09/28/2005CN1674925A Anti-microbial agent and anti-microbial composition
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674917A Treatment of human multiple myeloma by curcumin
09/28/2005CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
09/28/2005CN1674914A Female hormone-containing patch
09/28/2005CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674901A Novel salt and polymorphs of desloratadine hemifumarate
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674894A Ether substituted imidazopyridines
09/28/2005CN1674891A Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674881A Drug composition containing NF-kappa B inhibitor
09/28/2005CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent
09/28/2005CN1674864A Topical formulation for prevention and treatment of acne
09/28/2005CN1674863A Antiaging composition
09/28/2005CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion
09/28/2005CN1220699C Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use
09/28/2005CN1220696C 16 alpha-methyl or ethyl substituted estrogens
09/28/2005CN1220695C Inhibitors of nucleoside metabolism
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1564